World Alzheimer's Day 2021: The Power of Knowledge

World Alzheimer's Day is an international campaign organised by Alzheimer's Disease International to raise awareness and highlight issues faced by people affected by dementia. It takes place every year on September 21st and is the focus of World Alzheimer's Month.

Dementia is one of the biggest challenges we face, with nearly 50 million people living with dementia worldwide. Yet 2 out of every 3 people globally believe there is little or no understanding of dementia in their countries.The impact of World Alzheimer's Month is growing, but the stigmatisation and misinformation that surrounds dementia remains a global problem. To tackle this challenge, we need to collaborate and share best practice with one another.

In support of this year’s theme – ‘Know dementia, know Alzheimer's’ - Elsevier presents a curated, open access collection of over 70 journal articles and book chapters focused on shining a light on the warning signs of dementia and the importance of a timely diagnosis.

Elsevier,

Journal of Steroid Biochemistry and Molecular Biology, Volume 205, January 2021

Altered cholesterol metabolism is associated with increased risk of neurodegeneration and in particular with the development of Alzheimer’s disease (AD). Here, we investigate whether non-cholesterol sterols and oxysterols in the central nervous system are associated with (i) the presence of cerebral AD pathology, (ii) distinct aspects of AD pathology, i.e. amyloid pathology, neuronal injury, and tau pathology, and (iii) cognitive decline over time.
Elsevier,

Frontiers in Neuroendocrinology, Volume 60, January 2021

Greater cognitive reserve may protect against risk of developing AD/pathology. Sex differences in reserve may contribute to the elevated rate of AD in women.Historically women had less access to reserve contributors, increasing risk for AD. Access to reserve contributors benefits both sexes, particularly women.
Elsevier,

Medical Image Analysis, Volume 67, January 2021

Early detection and diagnosis of Alzheimer's disease, for improved indvidual health and well-being, and global social and economic improvement.
Elsevier,

JAAD Case Reports, Volume 6, December 2020

Case report exploring Covid skin manifestations in a patient with Alzheimers.
Elsevier,

Journal for Nurse Practitioners, Volume 16, 1 November 2020

Education, proactivity, technology, and cultural awareness can enable nursing-centered providers to lead interprofessional teams and provide access to quality care for individuals with dementia and their families. Some United States providers have adopted an approach aided by electronic smartphrase prompts for comprehensive dementia diagnosis and initial treatment supports that may be useful for other care providers.
Elsevier,

Cortex, Volume 132, November 2020

In the present study, to establish whether a misbinding impairment is present in sporadic late-onset Alzheimer's disease (LOAD) and increased guessing is a feature of Parkinson's disease (PD), we compared the performance of these patient groups to two control populations: healthy age-matched controls and individuals with subjective cognitive impairment (SCI) with comparable recruitment history as patients.
Elsevier,

Journal of the American Medical Directors Association, Volume 21, November 2020

This special open access article, published in a journal focused on post-acute and long-term care medicine, reports on the 2019 Alzheimer’s Association Dementia Care Provider Roundtable discussion. It lays out practice guidance on topics such as having a foundational person-centered culture.
Elsevier,

Cortex, Volume 131, October 2020

The present findings suggest that lexical semantic retrieval measures from existing story recall tasks may be sensitive to Aβ deposition, and may provide added utility to a widely-used, long-standing neuropsychological test for early detection of cognitive decline on the Alzheimer's disease continuum.
Elsevier,

Physiology and Behavior, Volume 223, 1 September 2020

Swimming exercise improved cognitive function, decreased anxiety-like behavior and reduced depression-like behavior in streptozotocin (STZ) -treated mice.
Elsevier,

Public Health, Volume 185, August 2020

Research into schools and knowledge of dementia, helping to raise awareness of dementia among adolescents.

Pages